Filters
reset allOther countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Expanded Renal Disease Panel Invitae United States | 693 | 388 |
|
COL4A3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 3 | 1 |
|
Invitae Nephrotic Syndrome and Focal Segmental Glomerulosclerosis (FSGS) Panel Invitae United States | 81 | 57 |
|
Invitae Comprehensive Deafness Panel Invitae United States | 405 | 219 |
|
Alport Syndrome Genetic Panel (2 Day STAT TAT) Machaon Diagnostics United States | 3 | 3 |
|
Invitae United States | 9 | 6 |
|
Alport syndrome, autosomal dominant, 104200, Autosomal dominant (Alport syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Alport syndrome, autosomal dominant, 104200, Autosomal dominant (Alport syndrome) (Prenatal) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Progressive Renal Disease Panel Invitae United States | 310 | 195 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Hereditary Hearing Loss and Deafness Panel PreventionGenetics, part of Exact Sciences United States | 360 | 222 |
|
Nephrotic syndrome and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 39 | 42 |
|
Nephrotic syndrome and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 39 | 42 |
|
Collagen Diagnostic Laboratory University Of Washington United States | 6 | 3 |
|
PreventionGenetics, part of Exact Sciences United States | 6 | 4 |
|
Nephrotic Syndrome (NS)/Focal Segmental Glomerulosclerosis (FSGS) Panel PreventionGenetics, part of Exact Sciences United States | 59 | 72 |
|
Alport Syndrome (AS) via the COL4A3 Gene PreventionGenetics, part of Exact Sciences United States | 3 | 1 |
|
Beacon Ashkenazi Jewish Male Carrier Screening Panel Fulgent Genetics United States | 145 | 41 |
|
Comprehensive Glomerular Proteinuria NGS Panel Fulgent Genetics United States | 182 | 76 |
|
Syndromic Hearing Loss NGS Panel Fulgent Genetics United States | 223 | 83 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.